EPIZYME, INC. Operating Lease, Payments
EPIZYME, INC. reported Operating Lease, Payments of $1.59 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-08-09
- EPIZYME, INC. operating lease, payments for the quarter ending 2022-06-30 was $1.59M, a 1.97% decline year-over-year.
- EPIZYME, INC. operating lease, payments for the quarter ending 2022-03-31 was $1.63M, a 1.37% increase year-over-year.
- EPIZYME, INC. operating lease, payments for the quarter ending 2021-12-31 was $1.61M, a 15.49% increase year-over-year.
- EPIZYME, INC. operating lease, payments for the quarter ending 2021-09-30 was $1.60M, a 60.10% increase year-over-year.
- EPIZYME, INC. operating lease, payments for fiscal 2021 was $6.44M, a 47.14% increase from fiscal 2020.
- EPIZYME, INC. operating lease, payments for fiscal 2020 was $4.37M, a 19.90% increase from fiscal 2019.
- EPIZYME, INC. operating lease, payments for fiscal 2019 was $3.65M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2022-06-30 | $1.59M 10-Q · filed 2022-08-09 | $3.22M 10-Q · filed 2022-08-09 | $4.83M derived: sum of 3 quarters · filed 2022-08-09 | $6.43M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $1.63M 10-Q · filed 2022-05-10 | $3.24M derived: sum of 2 quarters · filed 2022-05-10 | $4.84M derived: sum of 3 quarters · filed 2022-05-10 | $6.46M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.21M derived: sum of 2 quarters · filed 2022-03-01 | $4.83M derived: sum of 3 quarters · filed 2022-08-09 | $6.44M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-09 | $3.22M derived: sum of 2 quarters · filed 2022-08-09 | $4.83M 10-Q · filed 2021-11-09 | $6.22M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | $1.62M 10-Q · filed 2022-08-09 | $3.23M 10-Q · filed 2022-08-09 | $4.62M derived: sum of 3 quarters · filed 2022-08-09 | $5.62M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.60M 10-Q · filed 2022-05-10 | $3.00M derived: sum of 2 quarters · filed 2022-05-10 | $4.00M derived: sum of 3 quarters · filed 2022-05-10 | $5.00M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.39M derived: sum of 2 quarters · filed 2022-03-01 | $3.39M derived: sum of 3 quarters · filed 2022-03-01 | $4.37M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-09 | $2.00M derived: sum of 2 quarters · filed 2021-11-09 | $2.98M 10-Q · filed 2021-11-09 | $3.91M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-09 | $1.98M 10-Q · filed 2021-08-09 | $2.91M derived: sum of 3 quarters · filed 2022-03-01 | $3.82M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $981.00K 10-Q · filed 2021-05-06 | $1.91M derived: sum of 2 quarters · filed 2022-03-01 | $2.82M derived: sum of 3 quarters · filed 2022-03-01 | $3.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $929.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.84M derived: sum of 2 quarters · filed 2022-03-01 | $2.74M derived: sum of 3 quarters · filed 2022-03-01 | $3.65M 10-K · filed 2022-03-01 |
| 2019-09-30 | $907.00K 10-Q · filed 2020-11-06 | $1.81M derived: sum of 2 quarters · filed 2020-11-06 | $2.72M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $907.00K 10-Q · filed 2020-08-04 | $1.81M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $905.00K 10-Q · filed 2020-05-04 |